Results 201 to 210 of about 80,651 (264)

Chenodeoxycholic acid modulates cholestatic niche through FXR/Myc/P-selectin axis in liver endothelial cells. [PDF]

Nat Commun
Zhang P, Li X, Liang J, Zheng Y, Tong Y, Shen J, Chen Y, Han P, Chu S, Liu R, Zheng M, Zhai Y, Tang X, Zhang C, Qu H, Mi P, Chai J, Yuan D, Li S.   +18 more
europepmc   +1 more source

Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers. [PDF]

Sci Adv
Koshrovski-Michael S, Ajamil DR, Dey P, Kleiner R, Tevet S, Epshtein Y, Green Buzhor M, Khoury R, Pozzi S, Shenbach-Koltin G, Yeini E, Woythe L, Blau R, Scomparin A, Barshack I, Florindo HF, Lazar S, Albertazzi L, Amir RJ, Satchi-Fainaro R.   +19 more
europepmc   +1 more source

Soluble P-Selectin as an Indicator of Cutaneous Microangiopathy in Uncomplicated Young Patients with Type 1 Diabetes. [PDF]

Life (Basel)
Neubauer-Geryk J, Myśliwiec M, Zorena K, Bieniaszewski L.   +3 more
europepmc   +1 more source

Intact quantitation and evaluation of a PEG-glycosulfopeptide as a therapeutic P-selectin antagonist. [PDF]

RSC Adv
Park DD, Park SS, Dai E, Haller CA, Wong DJ, Wever WJ, Cummings RD, Chaikof EL.   +7 more
europepmc   +1 more source

P-Selectin Glycoprotein Ligand 1 [PDF]

, 2020
openaire   +1 more source

The role of P-selectin/PSGL-1 in regulating NETs as a novel mechanism in cerebral ischemic injury. [PDF]

Front Neurol
Li X, Ma Y, Wang D.
europepmc   +1 more source

Targeting the P-selectin/PSGL-1 pathway: discovery of disease-modifying therapeutics for disorders of thromboinflammation. [PDF]

Blood Vessel Thromb Hemost
Escopy S, Chaikof EL.
europepmc   +1 more source

Synthetic Retinoid Sulfarotene Selectively Inhibits Tumor-Repopulating Cells of Intrahepatic Cholangiocarcinoma via Disrupting Cytoskeleton by P-Selectin/PSGL1 N-Glycosylation Blockage. [PDF]

Adv Sci (Weinh)
Du X, Qi Z, Chen S, Wu J, Xu Y, Hu S, Yu Z, Hou J, Fang Y, Xia J, Cao X.   +10 more
europepmc   +1 more source

Soluble P-selectin as an inflammatory mediator potentially influencing endothelial activation in people living with HIV in sub-rural areas of Limpopo, South Africa. [PDF]

PLoS One
Mokoena H, Mabhida SE, Choshi J, Sekgala MD, Nkambule BB, Ndwandwe D, Mchiza ZJ, Kengne AP, Dludla PV, Hanser S.   +9 more
europepmc   +1 more source